Table 4 COX-1/-2 inhibitory properties of the tested agents at 10 μM.

From: Antiproliferation, 3D-multicellular spheroid and VEGFR-2 inhibitory properties of spiroindolin-2-ones with phosphonate function

Compd

% Inhibition of COX-1 ± SEM

% Inhibition of COX-2 ± SEM

SI

17a

49.8 ± 1.8

64.9 ± 2.8

0.96

17b

53.7 ± 3.7

61.3 ± 2.6

1.04

17c

58.6 ± 3.5

53.9 ± 1.7

1.05

17d

51.8 ± 2.2

56.4 ± 1.9

0.82

17e

55.0 ± 3.6

59.6 ± 1.3

1.08

17f

57.6 ± 1.1

60.8 ± 2.7

1.01

17g

62.1 ± 3.1

51.8 ± 2.8

0.96

17h

53.5 ± 2.8

51.5 ± 3.1

1.06

17i

46.2 ± 2.4

49.7 ± 1.9

1.09

17j

48.9 ± 1.5

53.5 ± 2.3

1.05

17k

57.7 ± 1.0

55.0 ± 1.6

1.30

17l

61.6 ± 1.2

50.3 ± 2.3

0.92

17m

58.3 ± 3.0

60.9 ± 1.1

0.93

17n

50.6 ± 2.3

47.3 ± 1.4

1.08

17o

61.7 ± 3.4

59.3 ± 2.4

1.14

17p

51.1 ± 2.7

53.5 ± 2.1

1.10

17q

61.3 ± 1.5

62.1 ± 3.1

0.93

17r

55.5 ± 2.6

51.8 ± 2.0

1.09

17s

53.8 ± 2.8

56.3 ± 2.3

0.83

17t

49.2 ± 1.9

63.7 ± 1.7

1.29

Ibuprofen

65.3 ± 1.2

71.3 ± 1.8

0.95

Indomethacin

64.3 ± 2.7

68.3 ± 1.6

1.09